Intensive Tobacco Treatment for Smoking Cessation in Cancer Patients
JD
KF
Overseen ByKayla Fay
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Dartmouth-Hitchcock Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to assess the cessation success rates of an intensive tobacco treatment program in a patients undergoing cancer treatment at 30 days, 3 months and 6 months.
Who Is on the Research Team?
JD
Joseph D Phillips, MD
Principal Investigator
Dartmouth-Hitchcock Medical Center
Are You a Good Fit for This Trial?
This trial is for adults aged 18 or older who are actively smoking at the time of their initial cancer consultation, which means they've smoked within the last two weeks. It's not open to those unable to consent or prisoners.Inclusion Criteria
You have been smoking within the past two weeks before your consultation for cancer.
Exclusion Criteria
Prisoners
I am unable to give consent for medical procedures.
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Intensive Tobacco Treatment
Participants receive intensive tobacco treatment with carbon monoxide monitoring, including counseling and pharmacotherapy as needed
6 months
Initial in-person visit, then biweekly via telephone or telehealth
Follow-up
Participants are monitored for cessation success rates at 30 days, 3 months, and 6 months
6 months
3 additional survey time points
What Are the Treatments Tested in This Trial?
Interventions
- Intensive Tobacco Treatment
Trial Overview The CORE study is testing how well an intensive tobacco treatment program helps cancer patients quit smoking. Success rates will be checked after 30 days, and then again at 3 and 6 months into the treatment.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Intensive Tobacco TreatmentExperimental Treatment1 Intervention
Group II: Usual Tobacco TreatmentActive Control1 Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dartmouth-Hitchcock Medical Center
Lead Sponsor
Trials
548
Recruited
2,545,000+
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.